United States Menopause Treatment Market with CAGR of 8.8% during 2023-2030 - Exclusive Report by DatamIntelligence

"Menopause Treatment Market is expected to grow at a CAGR of 8.8% during the forecasting period 2023-2030." As per DataM intelligence research report

Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/menopause-treatment-market?sp

United States: Recent Industry Developments

✅ In September 2025, Pfizer launched an oral therapy targeting moderate-to-severe vasomotor symptoms in menopausal women. The treatment improves quality of life and provides a non-hormonal alternative.

✅ In August 2025, Amgen initiated a Phase 3 clinical trial for a new selective estrogen receptor modulator (SERM) aimed at bone density improvement in postmenopausal women. The study supports innovative osteoporosis prevention strategies.

✅ In July 2025, TherapeuticsMD expanded its menopause care portfolio with the rollout of a digital health platform for symptom tracking and personalized therapy recommendations. The platform enhances patient engagement and adherence.

✅ In June 2025, Eli Lilly invested $120 million in R&D for novel hormone therapy formulations with reduced cardiovascular and metabolic risks. The initiative strengthens U.S. treatment options for menopause management.

Japan: Recent Industry Developments

✅ In September 2025, Takeda Pharmaceutical launched a non-hormonal oral therapy for menopausal symptom relief, focusing on hot flashes and sleep disturbances. The treatment supports women's health initiatives in Japan.

✅ In August 2025, Chugai Pharmaceutical initiated a clinical trial for a selective estrogen receptor modulator targeting bone loss in postmenopausal women. The study emphasizes safety and long-term efficacy.

✅ In July 2025, Daiichi Sankyo introduced a digital health platform for menopause symptom management, integrating AI-driven symptom tracking and personalized guidance. The platform improves treatment adherence and patient support.

✅ In June 2025, Astellas Pharma invested in R&D for novel non-hormonal therapies addressing vasomotor symptoms and mood disturbances in menopausal women. The initiative strengthens Japan's menopause treatment landscape.

Menopause Treatment Market: Drivers

The menopause treatment market is expanding due to the rising global aging female population and increasing awareness of menopausal symptoms such as hot flashes, mood swings, and osteoporosis. Hormone replacement therapy (HRT) remains a primary treatment option, offering relief from hormonal imbalances while improving quality of life. Advances in non-hormonal therapies, including plant-based supplements and selective estrogen receptor modulators, are providing additional options for symptom management. Growing focus on women's health and preventive care is driving greater adoption of menopause treatments. Increased patient education and awareness campaigns are encouraging women to seek timely medical intervention.

Technological innovations and clinical research are enabling the development of safer, more effective therapies with reduced side effects. Rising disposable incomes and improved access to healthcare in emerging markets are supporting market growth. Integration of digital health platforms, telemedicine, and personalized treatment plans enhances patient engagement and adherence. Healthcare providers are increasingly emphasizing holistic management approaches, combining lifestyle, dietary, and pharmacological interventions. With a growing emphasis on women's health and longevity, the menopause treatment market is poised for steady expansion.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/menopause-treatment-market?sp

Menopause Treatment Market: Major Players

Bayer Pharmaceuticals, Novo Nordisk A/S, Pfizer Inc., Allergan, Novartis AG, Teva Pharmaceutical Industries Ltd., Amneal Pharmaceuticals LLC., Novavax, Inc., Noven Pharmaceuticals, Duchesnay USA Inc.

Segment Covered in the Menopause Treatment Market:

➥ By Treatment: Hormonal Treatment, Estrogen, Progesterone

➥ By Combination: Non-Hormonal Treatment, Anti-Depressants, Others

➥ By Distribution Channel: Hospital Pharmacies, Online Stores, Retail Pharmacies

Research Process:

Both primary and secondary data sources have been used in the Menopause Treatment Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Most Frequently Asked Questions in the Menopause Treatment Market Research Industry:

➠ Who leads the Menopause Treatment industry and what's their competitive positioning regarding capacity, performance, and profitability?
➠ What growth opportunities and market challenges do Menopause Treatment market vendors face?
➠ Which segments show the highest growth potential and market share distribution?
➠ What factors are driving or limiting Menopause Treatment market growth?
➠ What are the dominant sales and distribution strategies in the Menopause Treatment industry?

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=menopause-treatment-market

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?sp

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.